Pipeline

Vidac has built a portfolio of novel product candidates that target significant unmet medical needs in oncology and dermatology.

read more

News

VIDAC PHARMA LTD ANNOUNCES WIDER SPECTRUM AUTHORIZATION OF ITS CTCL PHASE 2 CLINICAL TRIAL.

Vidac Pharma Ltd.: New Chemical Entities Patent Granted

Vidac Pharma Secures EUR 20m Capital Commitment From GEM

VIDAC PHARMA ANNOUNCES INCLUSION OF THE FIRST PATIENT IN A PLACEBO CONTROLLED PHASE II STUDY